Balance Function in Patients Post Corona Virus Disease 2019 (COVID-19)
Describing Balance Function in Patients Post-COVID-19
1 other identifier
observational
28
1 country
1
Brief Summary
The purpose of this study is to describe balance deficits in patients post COVID-19. The information the investigators learn may help influence balance training exercises for patients post-COVID-19. Participants will have a primary or secondary diagnosis of COVID-19 during hospitalization and off COVID-19 isolation and be receiving care in an acute inpatient hospital. Following consent, participants will complete balance assessments and questionnaires about balance and dizziness in a single session. Vital signs will be monitored during the session.The greatest risks of this study include shortness of breath, and a risk of falling or musculoskeletal soreness.These risks are no greater than those experienced during a usual physical therapy visit.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jul 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 2, 2021
CompletedFirst Posted
Study publicly available on registry
June 4, 2021
CompletedStudy Start
First participant enrolled
July 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 22, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 22, 2022
CompletedResults Posted
Study results publicly available
September 19, 2024
CompletedSeptember 19, 2024
September 1, 2024
11 months
June 2, 2021
September 8, 2023
September 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Motor Balance as Measured by Timed Up and Go (TUG)
The TUG measures mobility, motor balance, walking ability, and falls risk based on how long it takes the patient to stand up, walk 10 feet, turn around, walk back, and sit down. \< 10 seconds = normal, \< 20 seconds = good mobility; can walk outside alone; does not require a walking aid, \< 30 seconds = walking and balance problems; cannot walk outside alone; requires walking aid.
Baseline
Secondary Outcomes (2)
Sensory Influence on Balance as Measured by Modified Clinical Test of Sensory Interaction in Balance (mCTSIB)
Baseline
Balance Confidence as Measured by Activities Specific Balance Confidence (ABC) Scale
Baseline
Study Arms (1)
Patients who have tested positive for COVID-19
Patients who are designated as "COVID recovered" in the electronic medical record and who fit the inclusion criteria.
Interventions
There is no formal intervention in this study. The investigators will only be completing balance assessments with no follow-up visit.
Eligibility Criteria
Subjects will be adults who have primary or secondary diagnosis of COVID-19 during hospitalization and off COVID-19 isolation and be receiving care in an acute inpatient hospital (Duke University Health System).
You may qualify if:
- Age \> 18 years
- Primary or secondary diagnosis of COVID- 19 during hospitalization and off COVID-19 isolation
- Receiving care in acute inpatient
- Ability to ambulate 20' with or without an assistive device without dropping \>10% of resting oxygen saturation (determined from existing physical therapy evaluation)
- Ability to stand with no more than contact guard assistance (determined from existing physical therapy evaluation)
- Not requiring use of mechanical ventilation
- Minimum resting oxygen saturation of 88% with or without supplemental oxygen
- No neurological or orthopedic dysfunction that would affect balance
- Cognitively intact and able to follow directions and provide consent
You may not qualify if:
- History of 2 or more falls in the year prior to COVID-19 diagnosis or history of balance dysfunction
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke University Health System
Durham, North Carolina, 27615, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Ashley Poole
- Organization
- Duke University
Study Officials
- PRINCIPAL INVESTIGATOR
Ashley Poole
Duke Health
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 2, 2021
First Posted
June 4, 2021
Study Start
July 23, 2021
Primary Completion
June 22, 2022
Study Completion
June 22, 2022
Last Updated
September 19, 2024
Results First Posted
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share